Monogram Orthopaedics (MGRM) and The Competition Head-To-Head Survey

Monogram Orthopaedics (NASDAQ:MGRMGet Free Report) is one of 221 public companies in the “Surgical & medical instruments” industry, but how does it compare to its rivals? We will compare Monogram Orthopaedics to related businesses based on the strength of its analyst recommendations, risk, profitability, earnings, valuation, dividends and institutional ownership.

Institutional and Insider Ownership

0.5% of Monogram Orthopaedics shares are held by institutional investors. Comparatively, 47.9% of shares of all “Surgical & medical instruments” companies are held by institutional investors. 32.1% of Monogram Orthopaedics shares are held by insiders. Comparatively, 15.1% of shares of all “Surgical & medical instruments” companies are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Profitability

This table compares Monogram Orthopaedics and its rivals’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Monogram Orthopaedics N/A -143.70% -83.17%
Monogram Orthopaedics Competitors -673.74% -325.44% -30.33%

Valuation & Earnings

This table compares Monogram Orthopaedics and its rivals gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Net Income Price/Earnings Ratio
Monogram Orthopaedics $370,000.00 -$13.74 million -2.92
Monogram Orthopaedics Competitors $1.10 billion $4.12 million -10.03

Monogram Orthopaedics’ rivals have higher revenue and earnings than Monogram Orthopaedics. Monogram Orthopaedics is trading at a higher price-to-earnings ratio than its rivals, indicating that it is currently more expensive than other companies in its industry.

Analyst Recommendations

This is a breakdown of recent recommendations and price targets for Monogram Orthopaedics and its rivals, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Monogram Orthopaedics 0 0 0 0 N/A
Monogram Orthopaedics Competitors 1538 4128 8135 192 2.50

As a group, “Surgical & medical instruments” companies have a potential upside of 22.81%. Given Monogram Orthopaedics’ rivals higher probable upside, analysts clearly believe Monogram Orthopaedics has less favorable growth aspects than its rivals.

Summary

Monogram Orthopaedics rivals beat Monogram Orthopaedics on 5 of the 9 factors compared.

About Monogram Orthopaedics

(Get Free Report)

Monogram Orthopaedics, Inc. focuses on developing a product solution architecture to enable mass personalized optimization of orthopedic implants. The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures. Its robot prototype executes optimized paths for high-precision insertion of optimized implants in synthetic bone specimens. The company was formerly known as Monogram Arthroplasty Inc. and changed its name to Monogram Orthopaedics, Inc. in March 2017. The company was incorporated in 2016 and is headquartered in Austin, Texas.

Receive News & Ratings for Monogram Orthopaedics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monogram Orthopaedics and related companies with MarketBeat.com's FREE daily email newsletter.